Genetic screening technology: ethical issues in access to tests by employers and health insurance committees.
Whereas the introduction of new technologies previously has raised the ethical question of who ought to have access to a new procedure or device, genetic testing technology raises the new ethical question of to whom access to a new technology ought to be limited. In this article we discuss the implications of employers and private health insurance companies having access to genetic testing technology. Although there may be legitimate business interests in allowing employers and insurers to conduct genetic screening, there are other valid societal interests in regulating or limiting the use of this technology by third parties. Public policy developed in the area of new genetic technology must reflect such interests.
Faden
R R
RR
Program in Law, Ethics, and Health, Hampton House 511, 624 North Broadway, Baltimore, MD 21205, USA.
Kass
N E
NE
D004651:Employment / Q000941:ethics / Q000331:legislation & jurisprudence; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing / Q000941:ethics* / Q000331:legislation & jurisprudence / Q000379:methods; D033161:Government Regulation; D006801:Humans; D007343:Insurance Carriers / Q000331:legislation & jurisprudence; D015273:Insurance Selection Bias; D007348:Insurance, Health / Q000941:ethics; D009784:Occupational Diseases / Q000235:genetics; D016273:Occupational Exposure; D016272:Occupational Health; D011640:Public Policy; D012306:Risk; D014481:United States; D017132:Workplace